Navigation Links
NeurogesX Reports Fourth Quarter and Year-End 2007 Financial Results
Date:3/26/2008

call will also be available from the Investor Relations section on the corporate web site at http://www.neurogesx.com. A web cast replay can be accessed on the corporate web site beginning March 26, 2008 at approximately 6:00 p.m. ET. The replay will remain available until April 26, 2008.

About NGX-4010

NGX-4010 is a dermal patch containing capsaicin, a selective TRPV1 agonist, designed to manage peripheral neuropathic pain. NeurogesX has previously completed three Phase 3 studies in PHN, of which two met their primary endpoint. In the successful Phase 3 PHN studies, a single, 60-minute treatment with NGX-4010 applied directly to the site of pain reduced pain for up to 12 weeks. In addition to being studied in PHN, NGX-4010 was also studied in two Phase 3 clinical trials in painful HIV-DSP, one of which met its primary endpoint.

About NeurogesX, Inc.

NeurogesX (Nasdaq: NGSX) is a biopharmaceutical company focused on developing and commercializing novel pain management therapies. Its initial focus is on chronic peripheral neuropathic pain, including PHN, HIV-DSP and PDN. NeurogesX' late stage product portfolio is led by its product candidate NGX-4010, a dermal patch designed to manage pain associated with peripheral neuropathic pain conditions that NeurogesX believes offers significant advantages over other pain therapies.

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Act"). NeurogesX disclaims any intent or obligation to update these forward-looking statements, and claims the protection of the Safe Harbor for forward-looking statements conta
'/>"/>

SOURCE NeurogesX, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. NeurogesX to Report Third Quarter 2007 Financial Results on November 14, 2007
2. NeurogesX to Present at RBC Capital Markets 2007 Healthcare Conference
3. NeurogesX to Present at Susquehanna Financial Groups 2nd Annual SIGnificant Options in Healthcare Conference
4. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
5. Haemacure Reports Third Quarter 2007 Results
6. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
7. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
8. MDS Reports Third Quarter 2007 Results
9. Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006
10. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
11. NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... 2014 (HealthDay News) -- Even though its use is often ... Tylenol -- does not help treat lower back pain, according ... the drug was no more effective than a dummy pill ... pain. Besides showing no effect in easing discomfort, the ... sleep woes tied to back pain, nor did it improve ...
(Date:7/24/2014)... Attendances at emergency departments can be reduced by enabling ... visit their doctor,s surgery. This is just one of ... by researchers at the University of Bristol. , Called ... of systematic reviews, the report has been compiled by ... who looked at evidence from studies around the world. ...
(Date:7/24/2014)... have identified two previously undescribed radiological signs ... gastric bands. Adding widespread knowledge of the ... margin by more than 2.4 cm from ... air-fluid,level above the band on a frontal ... in diagnosing affected bariatric patients. These signs ...
(Date:7/24/2014)... Insecticides similar to nicotine, known as neonicotinoids, were ... to a new USGS study. This is the ... Midwestern United States and one of the first ... killing a broad range of insect pests, use ... last decade across the United States, particularly in ...
(Date:7/24/2014)... The National Resident Matching Program (NRMP) ... version of its smartphone app, The MATCH Program Rating ... in NRMP’s Main Residency Match® and Specialties Matching Service®. ... information during the interview process and develop program ratings ... lists. Rank order lists are used by the ...
Breaking Medicine News(10 mins):Health News:Acetaminophen May Not Help Against Back Pain, Study Contends 2Health News:Acetaminophen May Not Help Against Back Pain, Study Contends 3Health News:Seeing the same GP at every visit will reduce emergency department attendance 2Health News:Corn & soy insecticides similar to nicotine found widespread in Midwest rivers -- USGS news 2Health News:National Resident Matching Program® (NRMP®) Releases New, Enhanced Version of its Smartphone App 2Health News:National Resident Matching Program® (NRMP®) Releases New, Enhanced Version of its Smartphone App 3
... ongoing decline in the cancer death rate in the ... receive care that addresses the psychological and social problems ... psychological, emotional, and social side effects can increase patients, ... treatment. CANCER CARE FOR THE WHOLE PATIENT: MEETING ...
... October 16, 2007 -- Reducing the number of ... be more cost-effective than most public health and ... at Columbia University Mailman School of Public Health ... that class-size reductions would generate more quality-adjusted life-year ...
... 16 Expected to be,her family,s Halloween treat, Catharine ... pound, 10 ounces. Today, the five-year-old of,Allentown, Pennsylvania has ... who was born 16 weeks early, measuring only 12,inches ... half a million,babies born preterm each year in the ...
... (US Food Sources Preferred Over Imports), FRESNO, Calif., ... surveyed say their confidence in the food supply has,decreased ... conducted by,the California Olive Industry. The registered dieticians ... with 66% saying that when presented with a,choice, they ...
... NASHVILLE, Tenn., Oct. 16 HCA today announced the,appointment ... West Division,which is based in Las Vegas, effective Jan. ... retirement. As Far West Division President, Rogers will ... currently include nine,hospitals and seven ambulatory surgery centers with ...
... The Evening Will Feature Special Performances by John Legend, Joss Stone, ... ... The G&P Foundation for Cancer,Research will honor four outstanding individuals at ... Chief,Executive Officer of BET Networks Debra L. Lee, Chief Hematologic Oncology,Memorial ...
Cached Medicine News:Health News:Study shows reducing class size may be more cost-effective than most medical interventions 2Health News:March of Dimes Selects Pennsylvania Girl as 2008 National Ambassador 2Health News:Dieticians & Nutritionists Report Decreased Confidence in Food Supply 2Health News:Bryan R. Rogers Appointed President of Far West Division 2Health News:The G&P Foundation Celebrates 10 Years of Funding Life Saving Research at The 2007 Angel Ball Honoring Glenda Bailey, Debra L. Lee, Dr. Stephen D. Nimer and the Late H.H. Sheik Zayed Bin Sultan Al Nahyan 2Health News:The G&P Foundation Celebrates 10 Years of Funding Life Saving Research at The 2007 Angel Ball Honoring Glenda Bailey, Debra L. Lee, Dr. Stephen D. Nimer and the Late H.H. Sheik Zayed Bin Sultan Al Nahyan 3Health News:The G&P Foundation Celebrates 10 Years of Funding Life Saving Research at The 2007 Angel Ball Honoring Glenda Bailey, Debra L. Lee, Dr. Stephen D. Nimer and the Late H.H. Sheik Zayed Bin Sultan Al Nahyan 4Health News:The G&P Foundation Celebrates 10 Years of Funding Life Saving Research at The 2007 Angel Ball Honoring Glenda Bailey, Debra L. Lee, Dr. Stephen D. Nimer and the Late H.H. Sheik Zayed Bin Sultan Al Nahyan 5
(Date:7/24/2014)...  Bruin Biometrics (BBI), a pioneer in biometric-sensor ... weeks of clinical briefings to over 200 pressure ... substantial concurrence on both the clinical validity of ... BBI,s SEM Scanner. "From our ... drawn from the European Wound Management Association (EWMA) ...
(Date:7/24/2014)... -- As part of its ongoing effort to help women pharmacists ... Ownership Boot Camp on July 26 as part of the ... D.C. The Boot Camp is designed ... own their own pharmacies.  Now in its third year, the ... women pharmacists who dream of owning a pharmacy.   ...
(Date:7/24/2014)... 2014 Lpath, Inc. (NASDAQ: ... therapeutics, reported interim results in a Phase 2a ... as a treatment for metastatic renal cell carcinoma ... one therapy involving a VEGF inhibitor (e.g., Sutent®/ ... inhibitor (e.g., Afinitor®/everolimus), with a maximum of three ...
Breaking Medicine Technology:Bruin Biometrics Secures Support of EU Scientific Community for its SEM Scanner Technology 2'Women in Pharmacy' Program Seeks to Expand Pharmacy Ownership 2'Women in Pharmacy' Program Seeks to Expand Pharmacy Ownership 3'Women in Pharmacy' Program Seeks to Expand Pharmacy Ownership 4Lpath Reports Interim Data From Phase 2a Study for Anti-Cancer Drug, ASONEP 2Lpath Reports Interim Data From Phase 2a Study for Anti-Cancer Drug, ASONEP 3Lpath Reports Interim Data From Phase 2a Study for Anti-Cancer Drug, ASONEP 4
... SHANGHAI, Feb. 21, 2012 /PRNewswire-Asia/ -- ShangPharma Corporation (NYSE: ... leading China-based pharmaceutical and biotechnology research and development outsourcing ... Annual Health Care Conference, to be held in Boston, ... Xie, Vice President of Finance and Investor Relations of ...
... 2012  NewCrop LLC has selected Verizon Enterprise ... NewCrop,s new electronic system for prescribing controlled ... tailored digital identity solution, Verizon Universal ... submit electronic prescriptions for controlled substances via ...
Cached Medicine Technology:NewCrop Chooses Verizon to Help Provide Secure Electronic Prescriptions for Controlled Substances 2NewCrop Chooses Verizon to Help Provide Secure Electronic Prescriptions for Controlled Substances 3
Raysoft Foldable Intraocular Lens....
XL OCTO Hydrophilic Acrylic Lens....
... The Collamer™ lens, model CQ2003V, combines the ... design. This lens contains a Collamer optic ... no angulation. These loops offer flexibility comparable ... tensile strength, and superior "shape memory". The ...
Biocryl™ Acrylic Foldable Lens....
Medicine Products: